

Budapest – Ceva’s Hungarian Headquarters
Since the founding of Phylaxia in 1912, our presence in Hungary dates back more than a century. We remain proud of our heritage, which serves as the foundation for our continuous development.
We currently employ more than 1,400 people, and our team is steadily expanding.
Our Budapest site is a cornerstone of the Ceva Group, both locally and globally. In addition to producing 50 different vaccines to prevent 25 diseases, it hosts the group's largest biological R&D center and our SSIU Directorate.
Monor – The Future of Our Expansion
Since 2021, we have been operating across two locations. Our 50-hectare greenfield Linilog logistics center in Monor is unique in Europe: alongside storage and logistics operations, active manufacturing is also currently taking place here. In addition, it houses the continent’s largest cryogenic vaccine storage system, where products are stored at –196°C in liquid nitrogen.
The Monor site will accommodate additional operations in the future. A new manufacturing facility is currently under development and will, according to plans, begin operations in 2027, creating 120 new high-skilled jobs.


